Beauty Health price target raised to $4 from $2.50 at TD Cowen

TD Cowen analyst Oliver Chen raised the firm’s price target on Beauty Health to $4 from $2.50 and keeps a Market Perform rating on the shares. The firm said Q23 EPS and 2024 guide were better than feared and with a 2H weighted projection. 1Q guide was slightly below Street but believe expectations heading into the print were modest given the leadership change and disruptions with Syndeo.